Bank Of America Corp Icosavax, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.95 - $15.79 $63,450 - $168,384	10,664 Added 43.34%	35,272 $555,000
Q2 2023 Aug 14, 2023	SELL	$4.89 - $10.57 $76,117 - $164,532	-15,566 Reduced 38.75%	24,608 $244,000
Q1 2023 May 12, 2023	BUY	$5.62 - $11.51 $80,236 - $164,328	14,277 Added 55.13%	40,174 $233,000
Q4 2022 Feb 10, 2023	BUY	$2.32 - $10.97 $34,338 - $162,366	14,801 Added 133.39%	25,897 $205,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $9.21 $14,946 - $44,548	4,837 Added 77.28%	11,096 $35,000
Q2 2022 Aug 12, 2022	SELL	$5.7 - $10.33 $314,850 - $570,598	-55,237 Reduced 89.82%	6,259 $35,000
Q1 2022 May 16, 2022	BUY	$4.41 - $22.5 $255,347 - $1.3 Million	57,902 Added 1611.07%	61,496 $433,000
Q4 2021 Feb 08, 2022	BUY	$21.07 - $34.98 $46,733 - $77,585	2,218 Added 161.19%	3,594 $82,000
Q3 2021 Nov 15, 2021	BUY	$24.85 - $40.25 $34,193 - $55,384	1,376 New	1,376 $41,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.